ArticleAmerican journal of neurodegenerative disease2014

Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat.

Alex E Roher et al.PubMed ↗Full text ↗

No numbers read from the abstract.